These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15774430)

  • 1. Depression in multiple sclerosis: a review.
    Siegert RJ; Abernethy DA
    J Neurol Neurosurg Psychiatry; 2005 Apr; 76(4):469-75. PubMed ID: 15774430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cognitive disturbances and attempts of their correction in multiple sclerosis].
    Shmidt TE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(9):54-6. PubMed ID: 16252387
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of cognitive impairment in multiple sclerosis.
    Pierson SH; Griffith N
    Behav Neurol; 2006; 17(1):53-67. PubMed ID: 16720960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship of cognitive impairment with neurological and psychiatric variables in multiple sclerosis patients.
    Karadayi H; Arisoy O; Altunrende B; Boztas MH; Sercan M
    Int J Psychiatry Clin Pract; 2014 Jan; 18(1):45-51. PubMed ID: 24047424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Depression in multiple sclerosis].
    Lebrun C; Cohen M
    Rev Neurol (Paris); 2009 Mar; 165 Suppl 4():S156-62. PubMed ID: 19361681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive dysfunction in multiple sclerosis: natural history, pathophysiology and management.
    Bagert B; Camplair P; Bourdette D
    CNS Drugs; 2002; 16(7):445-55. PubMed ID: 12056920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuropsychiatric disorders in multiple sclerosis].
    García-Moreno JM; Duque P; Izquierdo G
    Rev Neurol; 2001 Sep 16-30; 33(6):560-7. PubMed ID: 11727241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychopharmacology of multiple sclerosis.
    Patten SB
    Handb Clin Neurol; 2019; 165():309-315. PubMed ID: 31727219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial.
    Schippling S; O'Connor P; Knappertz V; Pohl C; Bogumil T; Suarez G; Cook S; Filippi M; Hartung HP; Comi G; Jeffery DR; Kappos L; Goodin DS; Arnason B
    J Neurol; 2016 Jul; 263(7):1418-26. PubMed ID: 27177997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnitude and concurrence of anxiety and depression among attendees with multiple sclerosis at a tertiary care Hospital in Oman.
    Al-Asmi A; Al-Rawahi S; Al-Moqbali ZS; Al-Farsi Y; Essa MM; El-Bouri M; Koshy RP; Gujjar AR; Jacob PC; Al-Hodar A; Al Adawi S
    BMC Neurol; 2015 Aug; 15():131. PubMed ID: 26242758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond depression: Predictors of self-reported cognitive function in adults living with MS.
    Beier M; Amtmann D; Ehde DM
    Rehabil Psychol; 2015 Aug; 60(3):254-62. PubMed ID: 26192051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal consistency of the relationship between depression symptoms and cognitive functioning in multiple sclerosis.
    Arnett PA
    CNS Spectr; 2005 May; 10(5):372-82. PubMed ID: 15858455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis.
    Brown RF; Valpiani EM; Tennant CC; Dunn SM; Sharrock M; Hodgkinson S; Pollard JD
    Psychol Psychother; 2009 Mar; 82(Pt 1):41-56. PubMed ID: 18727845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neuropsychiatry of multiple sclerosis: focus on disorders of mood, affect and behaviour.
    Paparrigopoulos T; Ferentinos P; Kouzoupis A; Koutsis G; Papadimitriou GN
    Int Rev Psychiatry; 2010; 22(1):14-21. PubMed ID: 20233111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between depression and interferon beta-1a therapy in patients with multiple sclerosis.
    Patten SB; Francis G; Metz LM; Lopez-Bresnahan M; Chang P; Curtin F
    Mult Scler; 2005 Apr; 11(2):175-81. PubMed ID: 15794391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of interferon beta in the treatment of multiple sclerosis].
    Seeldrayers P
    Rev Med Brux; 1999 Sep; 20(4):A264-7. PubMed ID: 10523902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon beta-1 a and depression in relapsing-remitting multiple sclerosis: an analysis of depression data from the PRISMS clinical trial.
    Patten SB; Metz LM
    Mult Scler; 2001 Aug; 7(4):243-8. PubMed ID: 11548984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatigue and its relationships with cognitive functioning and depression in paediatric multiple sclerosis.
    Goretti B; Portaccio E; Ghezzi A; Lori S; Moiola L; Falautano M; Viterbo R; Patti F; Vecchio R; Pozzilli C; Bianchi V; Cappiello S; Comi G; Trojano M; Amato MP;
    Mult Scler; 2012 Mar; 18(3):329-34. PubMed ID: 21844064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Picconi O; Cilia S; Cottone S; Centonze D; Gasperini C;
    Mult Scler; 2011 Aug; 17(8):991-1001. PubMed ID: 21502310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.